173 related articles for article (PubMed ID: 38565630)
21. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.
Honda S; Hirabayashi H; Tsukahara Y; Negi A
Graefes Arch Clin Exp Ophthalmol; 2008 Jul; 246(7):1061-3. PubMed ID: 18320201
[TBL] [Abstract][Full Text] [Related]
22. Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study.
Wheeler DT; Dobson V; Chiang MF; Bremer DL; Gewolb IH; Phelps DL; Hardy RJ; Good WV; Fellows R; Tung BP; Palmer EA
Ophthalmology; 2011 Jun; 118(6):1145-51. PubMed ID: 21211840
[TBL] [Abstract][Full Text] [Related]
23. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
Kandasamy Y; Hartley L; Rudd D; Smith R
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
[TBL] [Abstract][Full Text] [Related]
24. Comparison of ultrasonic and ophthalmoscopic evaluation of retinopathy of prematurity.
Jokl DH; Silverman RH; Springer AD; Towers H; Kane S; Lopez R; Chiang MF; Lloyd HO; Barbazetto I; Horowitz R; Vidne O
J Pediatr Ophthalmol Strabismus; 2004; 41(6):345-50. PubMed ID: 15609519
[TBL] [Abstract][Full Text] [Related]
25. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
Early Treatment For Retinopathy Of Prematurity Cooperative Group
Arch Ophthalmol; 2003 Dec; 121(12):1684-94. PubMed ID: 14662586
[TBL] [Abstract][Full Text] [Related]
26. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
Kaempfen S; Neumann RP; Jost K; Schulzke SM
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
Liu X; Wang W; Wang AR; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
[TBL] [Abstract][Full Text] [Related]
29. [Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].
Walz JM; Bemme S; Reichl S; Akman S; Breuß H; Süsskind D; Glitz B; Müller VC; Wagenfeld L; Gabel-Pfisterer A; Aisenbrey S; Engelmann K; Koutsonas A; Krohne TU; Stahl A;
Ophthalmologe; 2018 Jun; 115(6):476-488. PubMed ID: 29637302
[TBL] [Abstract][Full Text] [Related]
30. Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling.
Sauer L; Chandler M; Hartnett ME
Am J Ophthalmol; 2024 Apr; 260():190-199. PubMed ID: 38141904
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of retinal structure in children with laser-treated retinopathy of prematurity versus controls - using optical coherence tomography.
Stoica F; Chirita-Emandi A; Andreescu N; Stanciu A; Zimbru CG; Puiu M
Acta Ophthalmol; 2018 Mar; 96(2):e222-e228. PubMed ID: 28926210
[TBL] [Abstract][Full Text] [Related]
32. Is there a role for high-frequency ultrasonography in clinical staging of retinopathy of prematurity?
Jokl DH; Silverman RH; Nemerofiky SL; Kane SA; Chiang MF; Lopez R; Lee G
J Pediatr Ophthalmol Strabismus; 2006; 43(1):31-5. PubMed ID: 16491723
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
34. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
Eldweik L; Mantagos IS
Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression.
Vural A; Ekinci DY; Onur IU; Hergünsel GO; Yiğit FU
Int Ophthalmol; 2019 Oct; 39(10):2267-2274. PubMed ID: 30604251
[TBL] [Abstract][Full Text] [Related]
36. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.
Adams GG; Bunce C; Xing W; Butler L; Long V; Reddy A; Dahlmann-Noor AH
BMJ Open; 2017 Mar; 7(3):e013366. PubMed ID: 28325857
[TBL] [Abstract][Full Text] [Related]
37. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R; Ramanathan R
Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
[TBL] [Abstract][Full Text] [Related]
38. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.
Baumal CR; Goldberg RA; Fein JG
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):432-8. PubMed ID: 25970863
[TBL] [Abstract][Full Text] [Related]
39. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.
Lee JY; Chae JB; Yang SJ; Yoon YH; Kim JG
Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.
Ekinci DY; Çelik K
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):54-60. PubMed ID: 31972042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
